Search

Your search keyword '"Grumach AS"' showing total 1,270 results
Start Over Author "Grumach AS"
1,270 results on '"Grumach AS"'

1. Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter study

Author

Pereira, Renan A., Dantas, Ellen O., Loekmanwidjaja, Jessica, Mazzucchelli, Juliana T. L., Aranda, Carolina S., Serrano, Maria E. G., De La Cruz Córdoba, Elisabeth A., Bezrodnik, Liliana, Moreira, Ileana, Ferreira, Janaira F. S., Dantas, Vera M., Sales, Valéria S. F., Fernandez, Carmen C., Vilela, Maria M. S., Motta, Isabela P., Franco, Jose Luis, Arango, Julio Cesar Orrego, Álvarez-Álvarez, Jesús A., Cardozo, Lina Rocío Riaño, Orellana, Julio C., Condino-Neto, Antonio, Kokron, Cristina M., Barros, Myrthes T., Regairaz, Lorena, Cabanillas, Diana, Suarez, Carmen L. N., Rosario, Nelson A., Chong-Neto, Herberto J., Takano, Olga A., Nadaf, Maria I. S. V., Moraes, Lillian S. L., Tavares, Fabiola S., Rabelo, Flaviane, Pino, Jessica, Calderon, Wilmer C., Mendoza-Quispe, Daniel, Goudouris, Ekaterini S., Patiño, Virginia, Montenegro, Cecilia, Souza, Monica S., Branco, Aniela BXCCastelo, Forte, Wilma C. N., Carvalho, Flavia A. A., Segundo, Gesmar, Cheik, Marina F. A., Roxo-Junior, Persio, Peres, Maryanna, Oliveira, Annie M., Neto, Arnaldo C. P., Ortega-López, Maria Claudia, Lozano, Alejandro, Lozano, Natalia Andrea, Nieto, Leticia H., Grumach, Anete S., Costa, Daniele C., Antunes, Nelma M. N., Nudelman, Victor, Pereira, Camila T. M., Martinez, Maria D. M., Quiroz, Francisco J. R., Cardona, Aristoteles A., Nuñez-Nuñez, Maria E., Rodriguez, Jairo A., Cuellar, Célia M., Vijoditz, Gustavo, Bichuetti-Silva, Daniélli C., Prando, Carolina C. M., Amantéa, Sérgio L., and Costa-Carvalho, Beatriz T.

Published
2024
Full Text
View/download PDF

2. Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network

Author

de Oliveira, Bibiana Mello, Bernardi, Filipe Andrade, Baiochi, João Francisco, Neiva, Mariane Barros, Artifon, Milena, Vergara, Alberto Andrade, Martins, Ana Maria, Grumach, Anete Sevciovic, Acosta, Angelina Xavier, Husny, Antonette Souto El, de Freitas Rodrigues Ribeiro, Bethania, Ramos, Camila Ferreira, Steiner, Carlos Eduardo, Kim, Chong Ae, Christofolini, Denise Maria, Yamada, Diego Bettiol, Carvalho, Ellaine Doris Fernandes, Ribeiro, Erlane Marques, de Arruda Bastos, Fabíola, Serpa, Faradiba Sarquis, Brandão, Flávia Reseda, Adjuto, Giselle Maria Araujo Felix, Carvalho, Isabelle, Saute, Jonas Alex Morales, Junior, Juan Clinton Llerena, Bueno, Larissa Souza Mario, da Silva, Luiz Carlos Santana, Santos, Mara Lucia Schmitz Ferreira, Costa, Marcela Câmara Machado, Giusti, Marcia Maria Costa Giacon, Galera, Marcial Francis, Filho, Márcio Eloi Colombo, de Andrade, Maria Denise Fernandes Carvalho, De Oliveira Cardoso, Maria Teresinha, de Menezes Ferreira, Marilaine Matos, Zeny, Michelle, Caldato, Milena Coelho Fernandes, Sorte, Ney Boa, Musolino, Nina Rosa de Castro, de Medeiros, Paula Frassinetti Vasconcelos, Zen, Paulo Ricardo Gazzola, Da Silva, Raquel Tavares Boy, Maia, Rayana Elias, Fock, Rodrigo, Almeida, Rosemarie Elizabeth Schimidt, Valle, Solange Oliveira Rodrigues, Amorim, Tatiana, Teixeira, Thaís Bomfim, Prazeres, Vania Mesquita Gadelha, de Faria Ferraz, Victor Evangelista, Lima, Vinicius Costa, Paiva, Wagner José Martins, Schwartz, Ida Vanessa Doederlein, Alves, Domingos, and Félix, Têmis Maria

Published
2024
Full Text
View/download PDF

3. Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network

Author

Bibiana Mello de Oliveira, Filipe Andrade Bernardi, João Francisco Baiochi, Mariane Barros Neiva, Milena Artifon, Alberto Andrade Vergara, Ana Maria Martins, Anete Sevciovic Grumach, Angelina Xavier Acosta, Antonette Souto El Husny, Bethania de Freitas Rodrigues Ribeiro, Camila Ferreira Ramos, Carlos Eduardo Steiner, Chong Ae Kim, Denise Maria Christofolini, Diego Bettiol Yamada, Ellaine Doris Fernandes Carvalho, Erlane Marques Ribeiro, Fabíola de Arruda Bastos, Faradiba Sarquis Serpa, Flávia Reseda Brandão, Giselle Maria Araujo Felix Adjuto, Isabelle Carvalho, Jonas Alex Morales Saute, Juan Clinton Llerena Junior, Larissa Souza Mario Bueno, Luiz Carlos Santana da Silva, Mara Lucia Schmitz Ferreira Santos, Marcela Câmara Machado Costa, Marcia Maria Costa Giacon Giusti, Marcial Francis Galera, Márcio Eloi Colombo Filho, Maria Denise Fernandes Carvalho de Andrade, Maria Teresinha De Oliveira Cardoso, Marilaine Matos de Menezes Ferreira, Michelle Zeny, Milena Coelho Fernandes Caldato, Ney Boa Sorte, Nina Rosa de Castro Musolino, Paula Frassinetti Vasconcelos de Medeiros, Paulo Ricardo Gazzola Zen, Raquel Tavares Boy Da Silva, Rayana Elias Maia, Rodrigo Fock, Rosemarie Elizabeth Schimidt Almeida, Solange Oliveira Rodrigues Valle, Tatiana Amorim, Thaís Bomfim Teixeira, Vania Mesquita Gadelha Prazeres, Victor Evangelista de Faria Ferraz, Vinicius Costa Lima, Wagner José Martins Paiva, Ida Vanessa Doederlein Schwartz, Domingos Alves, Têmis Maria Félix, and Raras Network Group

Subjects
Rare diseases, Public Health System, Brazil, Brazilian Rare Diseases Network, Medicine
Abstract

Abstract Background The Brazilian Policy for Comprehensive Care for People with Rare Diseases was implemented in 2014; however, national epidemiological data on rare diseases (RDs) are scarce and mainly focused on specific disorders. To address this gap, University Hospitals, Reference Services for Neonatal Screening, and Reference Services for Rare Diseases, all of which are public health institutions, established the Brazilian Rare Diseases Network (RARAS) in 2020. The objective of this study was to perform a comprehensive nationwide epidemiological investigation of individuals with RDs in Brazil. This retrospective survey collected data from patients receiving care in 34 healthcare facilities affiliated with RARAS in 2018 and 2019. Results The survey included 12,530 participants with a median age of 15.0 years, with women representing 50.5% of the cohort. Classification according to skin color demonstrated that 5044 (47.4%) participants were admixed. Most had a confirmed diagnosis (63.2%), with a predominance of phenylketonuria (PKU), cystic fibrosis (CF), and acromegaly. Common clinical manifestations included global developmental delay and seizures. The average duration of the diagnostic odyssey was 5.4 years (± 7.9 years). Among the confirmed diagnoses, 52.2% were etiological (biochemical: 42.5%; molecular: 30.9%), while 47.8% were clinical. Prenatal diagnoses accounted for 1.2%. Familial recurrence and consanguinity rates were 21.6% and 6.4%, respectively. Mainstay treatments included drug therapy (55.0%) and rehabilitation (15.6%). The Public Health System funded most diagnoses (84.2%) and treatments (86.7%). Hospitalizations were reported in 44.5% of cases, and the mortality rate was 1.5%, primarily due to motor neuron disease and CF. Conclusion This study marks a pioneering national-level data collection effort for rare diseases in Brazil, offering novel insights to advance the understanding, management, and resource allocation for RDs. It unveils an average diagnostic odyssey of 5.4 years and a higher prevalence of PKU and CF, possibly associated with the specialized services network, which included newborn screening services.

Published
2024
Full Text
View/download PDF

5. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

Author

Reshef, Avner, Buttgereit, Thomas, Betschel, Stephen D., Caballero, Teresa, Farkas, Henriette, Grumach, Anete S., Hide, Michihiro, Jindal, Ankur K., Longhurst, Hilary, Peter, Jonathan, Riedl, Marc A., Zhi, Yuxiang, Aberer, Werner, Abuzakouk, Mohamed, Al Farsi, Tariq, Al Sukaiti, Nashat, Al-Ahmad, Mona, Altrichter, Sabine, Aygören-Pürsün, Emel, Baeza, Maria Luisa, Bara, Noemi Anna, Bauer, Andrea, Bernstein, Jonathan A., Boccon-Gibod, Isabelle, Bonnekoh, Hanna, Bouillet, Laurence, Brzoza, Zenon, Bygum, Anette, Calderon, Oscar, de Albuquerque Campos, Regis, Campos Romero, Freya Helena, Cancian, Mauro, Chong-Neto, Herberto Jose, Christoff, George, Cimbollek, Stefan, Cohn, Danny M., Craig, Timothy, Danilycheva, Inna, Darlenski, Razvigor, Du-Thanh, Aurélie, Ensina, Luis Felipe, Fomina, Daria, Fonacier, Luz, Fukunaga, Atsushi, Gelincik, Asli, Giavina-Bianchi, Pedro, Godse, Kiran, Gompels, Mark, Goncalo, Margarida, Gotua, Maia, Guidos-Fogelbach, Guillermo, Guilarte, Mar, Kasperska-Zajac, Alicja, Katelaris, Constance H., Kinaciyan, Tamar, Kolkhir, Pavel, Kulthanan, Kanokvalai, Kurowski, Marcin, Latysheva, Elena, Lauerma, Antti, Launay, David, Lleonart, Ramon, Lumry, William, Malbran, Alejandro, Ali, Ramzy Mohammed, Nasr, Iman, Nieto-Martinez, Sandra, Parisi, Claudio, Pawankar, Ruby, Piñero-Saavedra, Macarena, Popov, Todor A., Porebski, Grzegorz, Prieto Garcia, Alicia, Pyatilova, Polina, Rudenko, Michael, Sekerel, Bulent Enis, Serpa, Faradiba Sarquis, Sheikh, Farrukh, Siebenhaar, Frank, Soria, Angèle, Staevska, Maria, Staubach, Petra, Stobiecki, Marcin, Thomsen, Simon Francis, Triggiani, Massimo, Valerieva, Anna, Valle, Solange, Van Dinh, Nguyen, Vera Ayala, Carolina Elisa, Zalewska-Janowska, Anna, Zanichelli, Andrea, Magerl, Markus, and Maurer, Marcus

Published
2024
Full Text
View/download PDF

6. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

Author

Maurer, Marcus, Magerl, Markus, Betschel, Stephen, Aberer, Werner, Ansotegui, Ignacio J, Aygören-Pürsün, Emel, Banerji, Aleena, Bara, Noémi-Anna, Boccon-Gibod, Isabelle, Bork, Konrad, Bouillet, Laurence, Boysen, Henrik Balle, Brodszki, Nicholas, Busse, Paula J, Bygum, Anette, Caballero, Teresa, Cancian, Mauro, Castaldo, Anthony J, Cohn, Danny M, Csuka, Dorottya, Farkas, Henriette, Gompels, Mark, Gower, Richard, Grumach, Anete S, Guidos-Fogelbach, Guillermo, Hide, Michihiro, Kang, Hye-Ryun, Kaplan, Allen P, Katelaris, Constance H, Kiani-Alikhan, Sorena, Lei, Wei-Te, Lockey, Richard F, Longhurst, Hilary, Lumry, William, MacGinnitie, Andrew, Malbran, Alejandro, Saguer, Inmaculada Martinez, Campos, Juan José Matta, Nast, Alexander, Nguyen, Dinh, Nieto-Martinez, Sandra A, Pawankar, Ruby, Peter, Jonathan, Porebski, Grzegorz, Prior, Nieves, Reshef, Avner, Riedl, Marc, Ritchie, Bruce, Sheikh, Farrukh Rafique, Smith, William B, Spaeth, Peter J, Stobiecki, Marcin, Toubi, Elias, Varga, Lilian Agnes, Weller, Karsten, Zanichelli, Andrea, Zhi, Yuxiang, Zuraw, Bruce, and Craig, Timothy

Subjects
Prevention, Clinical Research, C1-inhibitor, DELPHI, GRADE therapy, Hereditary angioedema, diagnosis, disease control, guideline, management, prophylaxis, quality of life, recommendations, self-administration, Clinical Sciences
Abstract

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.

Published
2022

8. Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria

Author

Christine J. Rubeiz, MD, Ricardo Asero, MD, Stephen Betschel, HBSc, MD, FRCP (C), Timothy Craig, DO, Anete Grumach, MD, PhD, Michihiro Hide, MD, PhD, David Lang, MD, Michael Levin, MD, PhD, Hilary Longhurst, MA, PhD, FRACP, FRCPath, Eli Magan, MD, Marcus Maurer, MD, Romi Saini, MD, Gordon Sussman, MD, Elias Toubi, MD, Dinh Nguyen Van, MD, PhD, Torsten Zuberier, MD, and Jonathan A. Bernstein, MD

Subjects
Chronic spontaneous urticaria, Clinical research, Safety, Adverse effects, Monitoring, Biologics, Immunologic diseases. Allergy, RC581-607
Abstract

Background: Chronic spontaneous urticaria (CSU) is a common condition treated by allergist/immunologists, but the only FDA-approved biologic medication, omalizumab, may be underutilized globally. Objective: This study was performed to determine the global prescription of omalizumab for treatment of CSU by allergists/immunologists. Methods: Anonymous questionnaire surveys were distributed online to World Allergy Organization (WAO) members worldwide. Categorical data were analyzed for descriptive analysis using one-way frequency tabulation in SAS 9.4. Results: There were 348 respondents (43 missing data); Average age 51 (range 28–90); M/F 48%/52%. 58% had > 15 years of clinical experience and 10%

Published
2024
Full Text
View/download PDF

9. 1809–1810

Author

Renate Grumach, Bastian Röther, Renate Grumach, Bastian Röther

Published
2023

11. Are pediatricians familiar with hereditary angioedema?

Author

Chong-Neto, Herberto José, Aroni, Bárbara Padilha, Mansour, Eli, Toledo, Eliana, Serpa, Faradiba Sarquis, Arruda, Luisa Karla, Giavina-Bianchi, Pedro, Valle, Solange Oliveira Rodrigues, de Moraes, Caroline Guth de Freitas Batista, Kruk, Tatielly, Chong-Silva, Débora Carla, Solé, Dirceu, Silva, Luciana Rodrigues, Grumach, Anete S., Rosário Filho, Nelson Augusto, and Campos, Régis de Albuquerque

Published
2023
Full Text
View/download PDF

13. SCID and Other Inborn Errors of Immunity with Low TRECs — the Brazilian Experience

Author

Barreiros, Lucila Akune, Sousa, Jusley Lira, Geier, Christoph, Leiss-Piller, Alexander, Kanegae, Marilia Pylles Patto, França, Tábata Takahashi, Boisson, Bertrand, Lima, Alessandra Miramontes, Costa-Carvalho, Beatriz Tavares, Aranda, Carolina Sanchez, de Moraes-Pinto, Maria Isabel, Segundo, Gesmar Rodrigues Silva, Ferreira, Janaira Fernandes Severo, Tavares, Fabíola Scancetti, Guimarães, Flávia Alice Timburiba de Medeiros, Toledo, Eliana Cristina, da Matta Ain, Ana Carolina, Moreira, Iramirton Figueirêdo, Soldatelli, Gustavo, Grumach, Anete Sevciovic, de Barros Dorna, Mayra, Weber, Cristina Worm, Di Gesu, Regina Sumiko Watanabe, Dantas, Vera Maria, Fernandes, Fátima Rodrigues, Torgerson, Troy Robert, Ochs, Hans Dietrich, Bustamante, Jacinta, Walter, Jolan Eszter, and Condino-Neto, Antonio

Published
2022
Full Text
View/download PDF

14. In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: A Brazilian cooperation

Author

Mendonça, Leonardo Oliveira, Toledo-Barros, Myrthes Anna Maragna, Leal, Vinicius Nunes Cordeiro, Roa, Mariela Estefany Gislene Vera, Cambuí, Raylane Adrielle Gonçalves, Toledo, Eliana, Barros, Samar Freschi, de Oliveira, Amanda Melato, Rivitti-Machado, Maria Cecília, Francescantonio, Isadora Carvalho Medeiros, Grumach, Anete Sevciovic, de Oliveira Penido, Norma, Castro, Fabio Fernandes Morato, Kalil, Jorge, and Pontillo, Alessandra

Published
2022
Full Text
View/download PDF

15. Are pediatricians familiar with hereditary angioedema?

Author

Herberto José Chong-Neto, M.D., Ph.D, Bárbara Padilha Aroni, M.D, Eli Mansour, M.D, Ph.D, Eliana Toledo, M.D., Ph.D, Faradiba Sarquis Serpa, M.D., Ph.D, Luisa Karla Arruda, M.D, Ph.D, Pedro Giavina-Bianchi, M.D., Ph.D, Solange Oliveira Rodrigues Valle, M.D., Ph.D, Caroline Guth de Freitas Batista de Moraes, M.T., MSc, Tatielly Kruk, M.T., MSc, Débora Carla Chong-Silva, MD, PhD, Dirceu Solé, M.D., Ph.D, Luciana Rodrigues Silva, M.D., Ph.D, Anete S. Grumach, M.D., Ph.D, Nelson Augusto Rosário Filho, M.D., Ph.D, and Régis de Albuquerque Campos, M.D., Ph.D

Subjects
Angioedema, Hereditary, Pediatrics, Knowledge, Surveys Questionnaires, Immunologic diseases. Allergy, RC581-607
Abstract

Background: Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent episodes of subcutaneous or mucosal edema caused by excess bradykinin. The aim of the present study was to assess the knowledge of pediatricians about hereditary angioedema. Methods: An online survey with 12 HAE-related and 14 demographics-related questions was e-mailed to all pediatricians who were members of the Brazilian Society of Pediatrics (n = 17 145) once a week during the months of June and July 2021. The electronic questionnaire assessed clinical manifestations, diagnosis, and treatment of hereditary angioedema in children and adolescents. Results: Four hundred and fifty-five pediatricians responded to the questionnaire (2.6%), of whom 55 (12.1%) were board certified in Allergy and Immunology (A/I), while 400 (87.9%) were not (N-A/I). Three hundred and sixty-eight (80.9%) were female, 289 (55.7%) were under 50 years of age, 286 (62.9%) graduated from Medical School more than 10 years previously, 83 (18.2%) held an MSc/PhD degree, and 253 (55.6%) were living in the Southeast Region of Brazil. The median number of correct answers to the questions related to HAE among A/I was 7 out of 12 (58.3%), with median ranging from 4.5 to 8 correct answers, while for N-A/I it was 3 (25%), with median ranging from 2.5 to 4 correct answers (p

Published
2023
Full Text
View/download PDF

16. Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review

Author

Anete S. Grumach, Noga Gadir, Aharon Kessel, Ashley Yegin, Inmaculada Martinez‐Saguer, and Jonathan A. Bernstein

Subjects
C1 inhibitor, guidelines, hereditary angioedema, management, quality of life, Immunologic diseases. Allergy, RC581-607
Abstract

Abstract Patients with hereditary angioedema (HAE) experience a high burden of disease due to unpredictable, painful, disfiguring, and potentially life‐threatening HAE attacks. Multiple HAE‐specific medications for the on‐demand treatment, short‐term and long‐term prophylaxis of HAE attacks have entered the market in recent years; however, the availability and access to these medications may vary between different countries. For this review, PubMed and EMBASE databases were searched for guidelines, consensus statements, and other publications on HAE management as well as publications on quality of life in patients with HAE. The current guidelines and recent literature on HAE management in specific countries are summarized with the aim to highlight the similarities and differences between guideline recommendations and the country‐specific clinical practice. Improvement in quality of life, which is a key goal in HAE management, is also discussed and the country‐specific trends are highlighted. Finally, the ways to achieve a more patient‐centric approach to HAE management within the framework set by the clinical management guidelines are examined.

Published
2023
Full Text
View/download PDF

20. C5b-C9 Deficiency

Author

Grumach, Anete Sevciovic, Sullivan, Kathleen, Section editor, Orange, Jordan Scott, editor, Chinen, Javier, editor, MacKay, Ian R., Series Editor, and Rose, Noel R., Series Editor

Published
2020
Full Text
View/download PDF

21. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Author

Ahn, Mi-Young, Akasbi, Miriam, Alatorre-Alexander, Jorge, Altclas, Javier David, Ariel, Federico, Ariza, Horacio Alberto, Atkar, Chandrasekhar, Bertetti, Anselmo, Bhattacharya, Meenakshi, Briones, Maria Luisa, Budhraja, Akshay, Burza, Aaliya, Camacho Ortiz, Adrian, Caricchio, Roberto, Casas, Marcelo, Cevoli Recio, Valeria, Choi, Won Suk, Cohen, Emilia, Comulada-Rivera, Angel, Cook, Paul, Cornejo Juarez, Dora Patricia, Daniel, Carnevali, Degrecci Relvas, Luiz Fernando, Dominguez Cherit, Jose Guillermo, Ellerin, Todd, Enikeev, Dmitry, Erico Tanni Minamoto, Suzana, Estrada, Vicente, Fiss, Elie, Furuichi, Motohiko, Giovanni Luz, Kleber, Goldman, Jason D., Gonzalez, Omar, Gordeev, Ivan, Gruenewald, Thomas, Hamamoto Sato, Victor Augusto, Heo, Eun Young, Heo, Jung Yeon, Hermida, Maria, Hirai, Yuji, Hutchinson, David, Iastrebner, Claudio, Ioachimescu, Octavian, Jain, Manish, Juliani Souza Lima, Maria Patelli, Khan, Akram, Kremer, Andreas E., Lawrie, Thomas, MacElwee, Mark, Madhani-Lovely, Farah, Malhotra, Vinay, Martínez Resendez, Michel Fernando, McKinnell, James, Milligan, Patrick, Minelli, Cesar, Moran Rodriguez, Miguel Angel, Parody, Maria Leonor, Paulin, Priscila, Pellegrini, Rita de Cassia, Pemu, Priscilla, Procopio Carvalho, Ana Carolina, Puoti, Massimo, Purow, Joshua, Ramesh, Mayur, Rea Neto, Alvaro, Robinson, Philip, Rodrigues, Cristhieni, Rojas Velasco, Gustavo, Saraiva, Jose Francisco Kerr, Scheinberg, Morton, Schreiber, Stefan, Scublinsky, Dario, Sevciovic Grumach, Anete, Shawa, Imad, Simon Campos, Jesus, Sofat, Nidhi, Som, Mousumi, Spinner, Christoph D., Sprinz, Eduardo, Stienecker, Roger, Suarez, Jose, Tachikawa, Natsuo, Tahir, Hasan, Tiffany, Brian, Vishnevsky, Alexander, Westheimer Cavalcante, Adilson, Zirpe, Kapil, Marconi, Vincent C, Ramanan, Athimalaipet V, de Bono, Stephanie, Kartman, Cynthia E, Krishnan, Venkatesh, Liao, Ran, Piruzeli, Maria Lucia B, Goldman, Jason D, de Cassia Pellegrini, Rita, Cardoso, Anabela, Chakladar, Sujatro, Crowe, Brenda, Reis, Paulo, Zhang, Xin, Adams, David H, and Ely, E Wesley

Published
2021
Full Text
View/download PDF

22. Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study

Author

Goudouris, Ekaterini Simões, Pinto-Mariz, Fernanda, Mendonça, Leonardo Oliveira, Aranda, Carolina Sanchez, Guimarães, Rafaela Rolla, Kokron, Cristina, Barros, Myrthes Toledo, Anísio, Flávia, Alonso, Maria Luiza Oliva, Marcelino, Fernanda, Valle, Solange Oliveira Rodrigues, Junior, Sergio Dortas, Barreto, Irma Douglas Paes, Ferreira, Janáira Fernandes Severo, Roxo-Junior, Pérsio, do Rego Silva, Almerinda Maria, Campinhos, Fernanda Lugão, Bonfim, Carmem, Loth, Gisele, Fernandes, Juliana Folloni, Garcia, Julia Lopes, Capelo, Albertina, Takano, Olga Akiko, Nadaf, Maria Isabel Valdomir, Toledo, Eliana C., Cunha, Luciana Araújo Oliveira, Di Gesu, Regina Sumiko Watanabe, Schidlowski, Laire, Fillipo, Priscila, Bichuetti-Silva, Daniélli C., Soldateli, Gustavo, Ferraroni, Natasha Rebouças, de Oliveira Dantas, Ellen, Pestana, Simone, Mansour, Eli, Ulaf, Raisa Gusso, Prando, Carolina, Condino-Neto, Antonio, and Grumach, Anete Sevciovic

Published
2021
Full Text
View/download PDF

25. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil

Author

Magaly Lima Mota, Robson dos Santos Souza Marinho, Rodrigo Lopes Sanz Duro, James Hunter, Irwin Rose Alencar de Menezes, João Marcos Ferreira de Lima Silva, Glaubervânio Leite Tavares Pereira, Ester Cerdeira Sabino, Anete Grumach, Ricardo Sobhie Diaz, Maria do Socorro Lucena, and Shirley Vasconcelos Komninakis

Subjects
Epidemiology, Dengue, Zika, Chikungunya, Brazil, Infectious and parasitic diseases, RC109-216
Abstract

Abstract Background The co-circulation of types of arbovirus in areas where they are endemic increased the risk of outbreaks and limited the diagnostic methods available. Here, we analyze the epidemiological profile of DENV, CHIKV and ZIKV at the serological and molecular level in patients with suspected infection with these arboviruses in the city of Juazeiro do Norte, Ceará, Brazil. Methods In 2016, the Central Public Health Laboratory (LACEN) of Juazeiro do Norte received 182 plasma samples from patients who visited health facilities with symptoms compatible with arbovirus infection. The LACEN performed serological tests for detection of IgM/IgG to DENV and CHIKV. They then sent these samples to the Retrovirology Laboratory of the Federal University of São Paulo and Faculty of Medical of the ABC where molecular analyses to confirm the infection by DENV, ZIKV and CHIKV were performed. The prevalence of IgM/IgG antibodies and of infections confirmed by RT-qPCR were presented with 95% confidence interval. Results In serologic analysis, 125 samples were positive for antibodies against CHIKV and all were positive for antibodies against DENV. A higher prevalence of IgG against CHIKV (63.20% with 95% CI: 45.76–70.56) than against DENV (95.05% with 95% CI: 78.09–98.12) was observed. When the samples were submitted to analysis by RT-qPCR, we observed the following prevalence: mono-infection by ZIKV of 19.23% (95% CI: 14.29–34.82) patients, mono-infection by CHIKV of 3.84% (95% CI: 2.01–5.44) and co-infection with ZIKV and CHIKV of 1.09% (95% CI: 0.89–4.56). Conclusion The serologic and molecular tests performed in this study were effective in analyzing the epidemiological profile of DENV, CHIKV and ZIKV in patients with suspected infection by these arboviruses in the city of Juazeiro do Norte, Ceará/Brazil.

Published
2021
Full Text
View/download PDF

27. The Panorama of Primary Angioedema in the Brazilian Population

Author

Cagini, Nathália, Mansour, Eli, da Silva, Jane, Giavina-Bianchi, Pedro, Teixeira, Ana Júlia, Valle, Solange Rodrigues, Goudouris, Ekaterini, Serpa, Faradiba Sarquis, Moyses, Therezinha R., Campinhos, Fernanda Lugão, Ensina, Luis Felipe, Aranda, Carolina Sánchez, Rizzo, Maria Cândida, Campos, Régis A., Gonçalves, Rozana Fátima, Minafra, Fernanda Gontijo, de Souza Bernardes, Marli, Chong-Neto, Herberto José, Filho, Nelson Rosário, Guth, Carolina, Toledo, Eliana, Coelho Dias, Gabriela Andrade, Piccirillo, Miguel Alberto, Severo Ferreira, Janáira Fernandes, Marcelino, Fernanda Casares, da Rocha Rolins Neto, Pedro, Franco, Jackeline Motta, Pafume de Sá, Gustavo, Garro, Laila Sabino, Carolina da Matta Ain, Ana, Velasco, Helena F., Fernandes Carvalho, Ellaine Dóris, Fernandes Carvalho de Andrade, Maria Denise, Boll, Cristiane Alves, Ferraroni, Natasha Rebouças, Martins Pinto Swensson, Ana Carolina, Vilela Rabelo, Leandro Augusto, Pacheco de Figueiredo, Joanemile, Figueredo, Raphael Coelho, Mendes, Ronney Corrêa, Sales, Valéria S.F., Bacarini Leite, Luiz Fernando, Beltran Moschione Castro, Ana Paula, Ferreira Mascarenhas, Elke C., Teixeira, Thais Bomfim, Campos Teixeira, Camila A., Pereira de Lira Marques, Adriana, Pires Amaral Resende, Ludmilla Luzia, Sandrin, Leda das Neves Almeida, Tavares, Clarissa Soares, Veronez, Camila Lopes, Mendes, Agatha Ribeiro, Leite, Caroliny Souza, Gomes, Caio Perez, Grumach, Anete Sevciovic, and Pesquero, João Bosco

Published
2021
Full Text
View/download PDF

30. The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation.

Author

Buttgereit, T., Aulenbacher, F., Gutsche, A., Kolkhir, P., Weller, K., Vera Ayala, C., Magerl, M., Farkas, H., Grumach, A. S., Aygören‐Pürsün, E., Bara, N., Ben‐Shoshan, M., Bernstein, J., Betschel, S., Bouillet, L., Caballero, T., Cancian, M., Castaldo, A. J., Cimbollek, S., and Cohn, D. M.

Subjects
SCIENTIFIC knowledge, RESEARCH personnel, MEDICAL research personnel, ADVISORY boards, RESEARCH grants
Abstract

The Chronic Angioedema Registry (CARE) is an international disease registry that aims to improve patient care for recurrent angioedema. It collects data through questionnaires completed by physicians and patients to assess disease control, quality of life, and treatment responses. However, the outcomes may not apply to less severe cases typically seen in primary care or community settings, and the findings may not be generalizable to patients from diverse ethnic backgrounds. The document also lists conflicts of interest for authors involved in the CARE study, who have disclosed financial relationships with pharmaceutical companies and other organizations. The study received approval from the Ethics Committee of Charité—Universitätsmedizin Berlin. [Extracted from the article]

Published
2024
Full Text
View/download PDF

32. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema

Author

Andrejevic, Sladjana, Aygören-Pürsün, Emel, Bara, Noemi-Anna, Bernstein, Jonathan, Bork, Konrad, Bouillet, Laurence, Bova, Maria, Boysen, Henrik Halle, Bygum, Anette, Caballero, Teresa, Castaldo, Anthony, Christiansen, Sandra, Cicardi, Marco, Fabiani, Jose, Katelaris, Connie, Dewald, Georg, Gökmen, Nihal M., Gonzalez-Quevedo, Maria Teresa, Gooi, Jimmy, Grivcheva-Panovska, Vesna, Grumach, Anete, Hakl, Roman, Hardy, Gaelle, Jesenak, Milos, Kaplan, Allen, Kirschfink, Michael, Köhalmi, Kinga Viktoria, Leibovich, Iris, Longhurst, Hilary J., Lumry, William, Magerl, Markus, Saguer, Inmaculada Martinez, Nagy, Imola Beatrix, Nieto, Sandra, Nordenfelt, Patrik, Porębski, Grzegorz, Psarros, Fotis, Reshef, Avner, Riedl, Marc A., Sheikh, Farrukh, Peter, Spath, Speletas, Matthaios, Staevska, Maria, Stobiecki, Marcin, Triggiani, Massimo, Veszeli, Nora, Waserman, Susan, Weber, Christina, Wuillemin, Walter, Zuraw, Bruce, Germenis, Anastasios E., Margaglione, Maurizio, Pesquero, João Bosco, Farkas, Henriette, Cichon, Sven, Csuka, Dorottya, Lera, Alberto López, Rijavec, Matija, Jolles, Stephen, Szilagyi, Agnes, Trascasa, Margarita López, Veronez, Camila Lopes, Drouet, Christian, and Zamanakou, Maria

Published
2020
Full Text
View/download PDF

35. The Brazilian Registry for Hereditary Angioedema: insights from the first 283 Patients

Author

Lemos, Jose, primary, Ferriani, Mariana, additional, Nunes, Fernanda, additional, Dias, Marina, additional, Giavina-Bianchi, Pedro, additional, Júnior, Pérsio Roxo, additional, Minafra, Fernanda, additional, Dias, Gabriela, additional, Serpa, Faradiba, additional, Marcelino, Fernanda, additional, Silva, jane, additional, Neto, Herberto Chong, additional, Gonçalves, Rozana, additional, Nogueira, Lucca, additional, Campos, Régis, additional, De Figueiredo, Joanemile, additional, Aun, Marcelo, additional, Teixeira, Ana, additional, Toledo, Eliana, additional, Moreira, Iramirton, additional, Valle, Solange, additional, Camargo, Anne, additional, Lopes, Fabiane, additional, Zanetti, Maria, additional, Neto, Orlando Trevisan, additional, Maia, Luana, additional, Traina, Fabiola, additional, Moreno, Adriana, additional, Kolarik, Maite, additional, Rosario, Nelson, additional, Guth, Caroline, additional, Aragon, Davi, additional, Arruda, Luisa Karla, additional, and Grumach, Anete, additional

Published
2024
Full Text
View/download PDF

37. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

Author

Marcus Maurer, MD, Markus Magerl, MD, Stephen Betschel, MD, Werner Aberer, MD, Ignacio J. Ansotegui, MD, PhD, Emel Aygören-Pürsün, MD, Aleena Banerji, MD, Noémi-Anna Bara, MD, Isabelle Boccon-Gibod, MD, Konrad Bork, MD, Laurence Bouillet, Pr, MD, PhD, Henrik Balle Boysen, Nicholas Brodszki, MD, PhD, Paula J. Busse, MD, Anette Bygum, MD, DMSci, Teresa Caballero, MD, PhD, Mauro Cancian, MD, PhD, Anthony J. Castaldo, Danny M. Cohn, MD, PhD, Dorottya Csuka, MD, Henriette Farkas, MD, PhD, DSc, Mark Gompels, MBBS, BSc, MD, Richard Gower, MD, Anete S. Grumach, MD, PhD, Guillermo Guidos-Fogelbach, MD, PhD, Michihiro Hide, MD, PhD, Hye-Ryun Kang, MD, PhD, Allen P. Kaplan, MD, Constance H. Katelaris, MBBS, PhD, Sorena Kiani-Alikhan, PhD, Wei-Te Lei, MD, Richard F. Lockey, MD, Hilary Longhurst, PhD, William Lumry, MD, Andrew MacGinnitie, MD, PhD, Alejandro Malbran, MD, PhD, Inmaculada Martinez Saguer, MD, Juan José Matta Campos, MD, Alexander Nast, MD, Dinh Nguyen, MD, PhD, Sandra A. Nieto-Martinez, MD, Ruby Pawankar, MD, PhD, Jonathan Peter, MB ChB, MMed, FCP (SA), PhD, Grzegorz Porebski, MD, Nieves Prior, MD, PhD, Avner Reshef, MD, Marc Riedl, MD, Bruce Ritchie, MD, Farrukh Rafique Sheikh, MBBS, William B. Smith, MBBS, PhD, Peter J. Spaeth, PhD, Marcin Stobiecki, MD, Elias Toubi, MD, Lilian Agnes Varga, PhD, Karsten Weller, MD, Andrea Zanichelli, MD, Yuxiang Zhi, MD, Bruce Zuraw, MD, and Timothy Craig, MD

Subjects
Hereditary angioedema, C1-inhibitor, diagnosis, GRADE therapy, management, disease control, Immunologic diseases. Allergy, RC581-607
Abstract

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.

Published
2022
Full Text
View/download PDF

38. Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor

Author

Natalia Gabriel, Fernanda Marcelino, Mariana P. L. Ferriani, L. Karla Arruda, Regis A. Campos, Rozana F. Gonçalves, Herberto Chong-Neto, Nelson Rosario Filho, Solange O. R. Valle, Joao B. Pesquero, and Anete S. Grumach

Subjects
pregnancy, hereditary angioedema, hereditary angioedema with normal C1 inhibitor, FXII, mutation, Immunologic diseases. Allergy, RC581-607
Abstract

BackgroundHAE with normal C1 inhibitor (HAE-nC1-INH) has been identified as a bradykinin mediated angioedema. Estrogens are one of the main trigger factors. Pregnancy in HAE with C1 inhibitor deficiency showed variable course, however, few reports are available for HAE-nC1-INH. We evaluated the course of pregnancies in women diagnosed with HAE-nC1-INH.MethodsWomen with diagnosis of HAE-nC1-INH according to the following criteria: clinical manifestations similar to HAE-C1-INH, normal biochemical evaluation and family history were included. A questionnaire about pregnancies was applied after consent. Genetic evaluation for known mutations was performed in all patients.ResultsA total of 45 pregnancies occurring in 26 HAE-nC1-INH patients were evaluated (7/26 patients with F12 variant). Spontaneous abortion was reported in 8/45 (17.8%) pregnancies. Onset of attacks started before the pregnancy in 18/26 patients; during the pregnancy in 2/26; and after the pregnancy in 6/26. HAE attacks occurred in 24/37 pregnancies (64,7%): during the 1st trimester in 41.7%; 2nd trimester in 12.5%; 3rd trimester in 20.8%; 1st and 3rd trimesters in 4.2% and during the whole pregnancy in 20.8%. Among 15/18 patients who had attacks before pregnancy, symptoms persisted with worsening in 9/15; improvement in 4/15; no change in 1/15, and no response in 1/15.ConclusionsThe occurrence of abortion in HAE-nC1-INH was similar to the expected for not affected women. The 1st trimester of the pregnancy was more symptomatic for HAE-nC1-INH women. Considering the strong relevance of estrogens in HAE-nC1-INH, pregnancy could worsen the course of disease.

Published
2022
Full Text
View/download PDF

40. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis

Author

Anete S. Grumach, Camila L. Veronez, Dorottya Csuka, and Henriette Farkas

Subjects
hereditary angioedema (HAE), angioedema without wheals, C1 inhibitor (C1-INH), C4, biomarker, diagnosis, Immunologic diseases. Allergy, RC581-607
Abstract

Angioedema is a prevailing symptom in different diseases, frequently occurring in the presence of urticaria. Recurrent angioedema without urticaria (AE) can be hereditary (HAE) and acquired (AAE), and several subtypes can be distinguished, although clinical presentation is quite similar in some of them. They present with subcutaneous and mucosal swellings, affecting extremities, face, genitals, bowels, and upper airways. AE is commonly misdiagnosed due to restricted access and availability of appropriate laboratorial tests. HAE with C1 inhibitor defect is associated with quantitative and/or functional deficiency. Although bradykinin-mediated disease results mainly from disturbance in the kallikrein–kinin system, traditionally complement evaluation has been used for diagnosis. Diagnosis is established by nephelometry, turbidimetry, or radial immunodiffusion for quantitative measurement of C1 inhibitor, and chromogenic assay or ELISA has been used for functional C1-INH analysis. Wrong handling of the samples can lead to misdiagnosis and, consequently, mistaken inappropriate approaches. Dried blood spot (DBS) tests have been used for decades in newborn screening for certain metabolic diseases, and there has been growing interest in their use for other congenital conditions. Recently, DBS is now proposed as an efficient tool to diagnose HAE with C1 inhibitor deficiency, and its use would improve the access to outbound areas and family members. Regarding HAE with normal C1 inhibitor, complement assays’ results are normal and the genetic sequencing of target genes, such as exon 9 of F12 and PLG, is the only available method. New methods to measure cleaved high-molecular-weight kininogen and activated plasma kallikrein have emerged as potential biochemical tests to identify bradykinin-mediated angioedema. Validated biomarkers of kallikrein–kinin system activation could be helpful in differentiating mechanisms of angioedema. Our aim is to focus on the capability to differentiate histaminergic AE from bradykinin-mediated AE. In addition, we will describe the challenges developing specific tests like direct bradykinin measurements. The need for quality tests to improve the diagnosis is well represented by the variability of results in functional assays.

Published
2021
Full Text
View/download PDF

42. Latin American consensus on the supportive management of patients with severe combined immunodeficiency

Author

Bustamante Ogando, Juan Carlos, Partida Gaytán, Armando, Aldave Becerra, Juan Carlos, Álvarez Cardona, Aristóteles, Bezrodnik, Liliana, Borzutzky, Arturo, Blancas Galicia, Lizbeth, Cabanillas, Diana, Condino-Neto, Antonio, De Colsa Ranero, Agustín, Espinosa Padilla, Sara, Fernandes, Juliana Folloni, García Campos, Jorge Alberto, Gómez Tello, Héctor, González Serrano, María Edith, Gutiérrez Hernández, Alonso, Hernández Bautista, Víctor Manuel, Ivankovich Escoto, Gabriele, King, Alejandra, Lessa Mazzucchelli, Juliana, Llamas Guillén, Beatriz Adriana, Lugo Reyes, Saul Oswaldo, Moreno Espinosa, Sarbelio, Oleastro, Matías, Otero Mendoza, Francisco, Poli Harlowe, María Cecilia, Porras, Oscar, Ramirez Uribe, Nideshda, Regairaz, Lorean, Rivas Larrauri, Francisco, Saracho Weber, Federico José, Grumach, Anete S., Staines Boone, Tamara, Tavares Costa-Carvalho, Beatriz, Yamazaki Nakashimada, Marco Antonio, and Espinosa Rosales, Francisco Javier

Published
2019
Full Text
View/download PDF

44. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies.

Author

Marciano, Beatriz, Huang, Chiung-Yu, Joshi, Gyan, Rezaei, Nima, Carvalho, Beatriz, Allwood, Zoe, Ikinciogullari, Aydan, Reda, Shereen, Gennery, Andrew, Thon, Vojtech, Espinosa-Rosales, Francisco, Al-Herz, Waleed, Porras, Oscar, Shcherbina, Anna, Szaflarska, Anna, Kiliç, Şebnem, Franco, Jose, Gómez Raccio, Andrea, Roxo, Persio, Esteves, Isabel, Galal, Nermeen, Grumach, Anete, Al-Tamemi, Salem, Yildiran, Alisan, Orellana, Julio, Yamada, Masafumi, Morio, Tomohiro, Liberatore, Diana, Ohtsuka, Yoshitoshi, Lau, Yu-Lung, Nishikomori, Ryuta, Torres-Lozano, Carlos, Mazzucchelli, Juliana, Vilela, Maria, Tavares, Fabiola, Cunha, Luciana, Pinto, Jorge, Espinosa-Padilla, Sara, Hernandez-Nieto, Leticia, Elfeky, Reem, Ariga, Tadashi, Toshio, Heike, Dogu, Figen, Cipe, Funda, Formankova, Renata, Nuñez-Nuñez, M, Bezrodnik, Liliana, Marques, Jose, Pereira, María, Listello, Viviana, Slatter, Mary, Nademi, Zohreh, Kowalczyk, Danuta, Fleisher, Thomas, Davies, Graham, Neven, Bénédicte, and Rosenzweig, Sergio

Subjects
BCG, Primary immunodeficiency, hematopoietic stem cell transplant, immune reconstitution syndrome, mycobacteria, newborn screening, severe combined immunodeficiency, vaccine, BCG Vaccine, Child, Preschool, Comorbidity, Female, Hematopoietic Stem Cell Transplantation, Humans, Infant, Infant, Newborn, Kaplan-Meier Estimate, Male, Prevalence, Retrospective Studies, Risk, Severe Combined Immunodeficiency, Vaccination
Abstract

BACKGROUND: Severe combined immunodeficiency (SCID) is a syndrome characterized by profound T-cell deficiency. BCG vaccine is contraindicated in patients with SCID. Because most countries encourage BCG vaccination at birth, a high percentage of patients with SCID are vaccinated before their immune defect is detected. OBJECTIVES: We sought to describe the complications and risks associated with BCG vaccination in patients with SCID. METHODS: An extensive standardized questionnaire evaluating complications, therapeutics, and outcomes regarding BCG vaccination in patients given a diagnosis of SCID was widely distributed. Summary statistics and association analysis was performed. RESULTS: Data on 349 BCG-vaccinated patients with SCID from 28 centers in 17 countries were analyzed. Fifty-one percent of the patients had BCG-associated complications, 34% disseminated and 17% localized (a 33,000- and 400-fold increase, respectively, over the general population). Patients receiving early vaccination (≤1 month) showed an increased prevalence of complications (P = .006) and death caused by BCG-associated complications (P < .0001). The odds of experiencing complications among patients with T-cell numbers of 250/μL or less at diagnosis was 2.1 times higher (95% CI, 1.4-3.4 times higher; P = .001) than among those with T-cell numbers of greater than 250/μL. BCG-associated complications were reported in 2 of 78 patients who received antimycobacterial therapy while asymptomatic, and no deaths caused by BCG-associated complications occurred in this group. In contrast, 46 BCG-associated deaths were reported among 160 patients treated with antimycobacterial therapy for a symptomatic BCG infection (P < .0001). CONCLUSIONS: BCG vaccine has a very high rate of complications in patients with SCID, which increase morbidity and mortality rates. Until safer and more efficient antituberculosis vaccines become available, delay in BCG vaccination should be considered to protect highly vulnerable populations from preventable complications.

Published
2014

48. Ataxia Telangiectasia in Latin America: clinical features, immunodeficiency and mortality in a multicenter study

Author

Pereira, Renan Augusto, primary, Dantas, Ellen O, additional, Loekmanwidjaja, Jessica, additional, Mazzucchelli, Juliana T L, additional, Aranda, Carolina S, additional, Serrano, Maria E G, additional, Bezrodnik, Liliana, additional, Moreira, Ileana, additional, Ferreira, Janaira F S, additional, Dantas, Vera M, additional, Sales, Valéria S F, additional, Fernandez, Carmen C, additional, Vilela, Maria M S, additional, Motta, Isabela P, additional, Franco, Jose Luis, additional, Arango, Julio Cesar Orrego, additional, Álvarez-Álvarez, Jesús A, additional, Cardozo, Lina Rocío Riaño, additional, Orellana, Julio C, additional, Condino-Neto, Antonio, additional, Kokron, Cristina M, additional, Barros, Myrthes T, additional, Regairaz, Lorena, additional, Cabanillas, Diana, additional, Suarez, Carmen L N, additional, Rosario, Nelson A, additional, Chong-Neto, Herberto J, additional, Takano, Olga A, additional, Nadaf, Maria I S V, additional, Moraes, Lillian S L, additional, Tavares, Fabiola S, additional, Rabelo, Flaviane, additional, Pino, Jessica, additional, Calderon, Wilmer C, additional, Mendoza-Quispe, Daniel, additional, Goudouris, Ekaterine S, additional, Patiño, Virginia, additional, Montenegro, Cecilia, additional, Souza, Monica S, additional, Branco, Aniela B X C Castelo, additional, Forte, Wilma C N, additional, Carvalho, Flavia A A, additional, Segundo, Gesmar, additional, Cheik, Marina F A, additional, Roxo-Junior, Persio, additional, Peres, Maryanna, additional, Oliveira, Annie M, additional, Neto, Arnaldo C P, additional, Ortega-López, Maria Claudia, additional, Lozano, Alejandro, additional, Lozano, Natalia Andrea, additional, Nieto, Leticia H, additional, Grumach, Anete S, additional, Costa, Daniele C, additional, Antunes, Nelma M N, additional, Nudelman, Victor, additional, Pereira, Camila T M, additional, Martinez, Maria D M, additional, Quiroz, Francisco J R, additional, Cardona, Aristoteles A, additional, Nuñes-Nuñes, Maria E, additional, Rodriguez, Jairo A, additional, Cuellar, Célia M, additional, Vijoditz, Gustavo, additional, Bichuetti-Silva, Daniélli C, additional, Prando, Carolina C M, additional, Amantéa, Sérgio L, additional, Costa-Carvalho, Beatriz T, additional, and Córdoba, Elizabeth A De La Cruz, additional

Published
2023
Full Text
View/download PDF

49. The International/Canadian Hereditary Angioedema Guideline

Author

Stephen Betschel, Jacquie Badiou, Karen Binkley, Rozita Borici-Mazi, Jacques Hébert, Amin Kanani, Paul Keith, Gina Lacuesta, Susan Waserman, Bill Yang, Emel Aygören-Pürsün, Jonathan Bernstein, Konrad Bork, Teresa Caballero, Marco Cicardi, Timothy Craig, Henriette Farkas, Anete Grumach, Connie Katelaris, Hilary Longhurst, Marc Riedl, Bruce Zuraw, Magdelena Berger, Jean-Nicolas Boursiquot, Henrik Boysen, Anthony Castaldo, Hugo Chapdelaine, Lori Connors, Lisa Fu, Dawn Goodyear, Alison Haynes, Palinder Kamra, Harold Kim, Kelly Lang-Robertson, Eric Leith, Christine McCusker, Bill Moote, Andrew O’Keefe, Ibraheem Othman, Man-Chiu Poon, Bruce Ritchie, Charles St-Pierre, Donald Stark, and Ellie Tsai

Subjects
Hereditary angioedema, Guideline, Recommendations, Pediatrics, Pregnancy, Acute attacks, Immunologic diseases. Allergy, RC581-607
Abstract

Abstract This is an update to the 2014 Canadian Hereditary Angioedema Guideline with an expanded scope to include the management of hereditary angioedema (HAE) patients worldwide. It is a collaboration of Canadian and international HAE experts and patient groups led by the Canadian Hereditary Angioedema Network. The objective of this guideline is to provide evidence-based recommendations, using the GRADE system, for the management of patients with HAE. This includes the treatment of attacks, short-term prophylaxis, long-term prophylaxis, and recommendations for self-administration, individualized therapy, quality of life, and comprehensive care. New to the 2019 version of this guideline are sections covering the diagnosis and recommended therapies for acute treatment in HAE patients with normal C1-INH, as well as sections on pregnant and paediatric patients, patient associations and an HAE registry. Hereditary angioedema results in random and often unpredictable attacks of painful swelling typically affecting the extremities, bowel mucosa, genitals, face and upper airway. Attacks are associated with significant functional impairment, decreased health-related quality of life, and mortality in the case of laryngeal attacks. Caring for patients with HAE can be challenging due to the complexity of this disease. The care of patients with HAE in Canada, as in many countries, continues to be neither optimal nor uniform. It lags behind some other countries where there are more organized models for HAE management, and greater availability of additional licensed therapeutic options. It is anticipated that providing this guideline to caregivers, policy makers, patients, and advocates will not only optimize the management of HAE, but also promote the importance of individualized care. The primary target users of this guideline are healthcare providers who are managing patients with HAE. Other healthcare providers who may use this guideline are emergency and intensive care physicians, primary care physicians, gastroenterologists, dentists, otolaryngologists, paediatricians, and gynaecologists who will encounter patients with HAE and need to be aware of this condition. Hospital administrators, insurers and policy makers may also find this guideline helpful.

Published
2019
Full Text
View/download PDF

50. Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey

Author

Anette Bygum, Teresa Caballero, Anete S. Grumach, Hilary J. Longhurst, Laurence Bouillet, Werner Aberer, Andrea Zanichelli, Jaco Botha, Irmgard Andresen, Marcus Maurer, and for the IOS Study Group

Subjects
Hereditary angioedema, Icatibant Outcome Survey, Safety, Elderly, Immunologic diseases. Allergy, RC581-607
Abstract

Abstract Background Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling in subcutaneous or submucosal tissues. Symptoms often begin by age 5–11 years and worsen during puberty, but attacks can occur at any age and recur throughout life. Disease course in elderly patients is rarely reported. Methods The Icatibant Outcome Survey (IOS) is an observational study evaluating the safety, tolerability, and efficacy of icatibant. We conducted descriptive analyses in younger (age

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results